Literature DB >> 6315150

The effects of cholecystokinin on dopaminergic mechanisms in rat striatum.

R D Mashal, F Owen, J F Deakin, M Poulter.   

Abstract

Intraventricular administration of cholecystokinin-octapeptide in unanesthetized rats results in a significant reduction in the number of [3H]spiperone binding sites. Striatal levels of the dopamine metabolites 3,4-dihydroxyphenylacetic acid and homovanillic acid were significantly reduced, whereas there was no significant reduction in the levels of the serotonin metabolite 5-hydroxyindoleacetic acid.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6315150     DOI: 10.1016/0006-8993(83)90949-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  2 in total

1.  Infusions of cholecystokinin octapeptide into the ventral tegmental area potentiate amphetamine conditioned place preferences.

Authors:  H O Pettit; K Mueller
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Regional changes in neuropeptide levels after 5,7-dihydroxytryptamine-induced serotonin depletion in the rat brain.

Authors:  Y Kondo; N Ogawa; M Asanuma; H Hirata; K Tanaka; Y Kawada; A Mori
Journal:  J Neural Transm Gen Sect       Date:  1993
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.